Ubs Group Ag Biomarin Pharmaceutical Inc Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $379,610 - $516,120	5,500 Added 73.33%	13,000 $913,000
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $628,575 - $742,500	7,500 New	7,500 $655,000
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $1.52 Million - $1.76 Million	17,500 New	17,500 $1.52 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $5.61 Million - $6.62 Million	68,272 New	68,272 $5.79 Million
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $1.49 Million - $1.67 Million	19,740 Added 7592.31%	20,000 $1.67 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $2.14 Million - $3.9 Million	-29,740 Reduced 99.13%	260 $20,000
Q2 2020 Jul 31, 2020	BUY	$79.55 - $124.22 $377,067 - $588,802	4,740 Added 18.76%	30,000 $3.7 Million
Q1 2020 May 01, 2020	SELL	$71.37 - $96.85 $473,896 - $643,084	-6,640 Reduced 20.82%	25,260 $2.13 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $443,463 - $595,953	6,900 Added 27.6%	31,900 $2.7 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $1.67 Million - $2.11 Million	24,750 Added 9900.0%	25,000 $1.69 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $46,310 - $54,241	-550 Reduced 68.75%	250 $22,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $38,005 - $49,515	500 Added 166.67%	800 $75,000
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $1.09 Million - $1.3 Million	-14,032 Reduced 97.91%	300 $24,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $806,630 - $950,158	-9,988 Reduced 41.07%	14,332 $1.28 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.94 Million - $2.28 Million	24,020 Added 8006.67%	24,320 $2.26 Million
Q1 2017 Nov 14, 2017	BUY	N/A	300	300 $26,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account